Bactiguard Holding Toekomstige groei
Future criteriumcontroles 1/6
Bactiguard Holding is forecast to grow earnings and revenue by 67% and 7.5% per annum respectively. EPS is expected to grow by 67.1% per annum. Return on equity is forecast to be -10.9% in 3 years.
Belangrijke informatie
67.0%
Groei van de winst
67.1%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 22.8% |
| Inkomstengroei | 7.5% |
| Toekomstig rendement op eigen vermogen | -10.9% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 14 Feb 2024 |
Recente toekomstige groei-updates
Geen updates
Recent updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2025 | 237 | -28 | N/A | N/A | 1 |
| 12/31/2024 | 212 | -79 | N/A | N/A | 1 |
| 12/31/2023 | 204 | -138 | -61 | -52 | N/A |
| 9/30/2023 | 211 | -125 | -62 | -55 | N/A |
| 6/30/2023 | 224 | -109 | -23 | -11 | N/A |
| 3/31/2023 | 233 | -58 | -4 | 7 | N/A |
| 12/31/2022 | 227 | -53 | -8 | 3 | N/A |
| 9/30/2022 | 209 | -64 | -24 | -16 | N/A |
| 6/30/2022 | 193 | -66 | -13 | -11 | N/A |
| 3/31/2022 | 186 | -65 | -8 | -4 | N/A |
| 12/31/2021 | 172 | -59 | 0 | 7 | N/A |
| 9/30/2021 | 216 | -44 | 10 | 23 | N/A |
| 6/30/2021 | 203 | -50 | -11 | 5 | N/A |
| 3/31/2021 | 170 | -38 | -14 | 3 | N/A |
| 12/31/2020 | 177 | -38 | -15 | 1 | N/A |
| 9/30/2020 | 155 | -26 | 26 | 34 | N/A |
| 6/30/2020 | 187 | 14 | 55 | 61 | N/A |
| 3/31/2020 | 206 | 9 | 53 | 57 | N/A |
| 12/31/2019 | 190 | 16 | 50 | 54 | N/A |
| 9/30/2019 | 155 | 9 | 7 | 14 | N/A |
| 6/30/2019 | 128 | -15 | -10 | -4 | N/A |
| 3/31/2019 | 149 | -10 | 0 | 7 | N/A |
| 12/31/2018 | 150 | -15 | -5 | 1 | N/A |
| 9/30/2018 | 160 | -10 | -6 | 1 | N/A |
| 6/30/2018 | 159 | -10 | -4 | 3 | N/A |
| 3/31/2018 | 143 | -15 | -12 | -5 | N/A |
| 12/31/2017 | 151 | -3 | 0 | 6 | N/A |
| 9/30/2017 | 142 | -10 | N/A | -8 | N/A |
| 6/30/2017 | 142 | -10 | N/A | -14 | N/A |
| 3/31/2017 | 140 | -12 | N/A | -18 | N/A |
| 12/31/2016 | 124 | -27 | N/A | -12 | N/A |
| 9/30/2016 | 116 | -39 | N/A | -18 | N/A |
| 6/30/2016 | 139 | -32 | N/A | -6 | N/A |
| 3/31/2016 | 133 | -34 | N/A | -11 | N/A |
| 12/31/2015 | 135 | -27 | N/A | -21 | N/A |
| 9/30/2015 | 120 | -39 | N/A | -30 | N/A |
| 6/30/2015 | 87 | -61 | N/A | -60 | N/A |
| 3/31/2015 | 88 | -95 | N/A | -62 | N/A |
| 12/31/2014 | 95 | -111 | N/A | -36 | N/A |
| 9/30/2014 | 137 | -60 | N/A | -47 | N/A |
| 6/30/2014 | 143 | -50 | N/A | -28 | N/A |
| 3/31/2014 | 136 | -20 | N/A | -25 | N/A |
| 12/31/2013 | 129 | -3 | N/A | -45 | N/A |
| 9/30/2013 | 110 | -20 | N/A | -54 | N/A |
| 6/30/2013 | 104 | -32 | N/A | -54 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: 0QV2 is forecast to remain unprofitable over the next 3 years.
Winst versus markt: 0QV2 is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: 0QV2 is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: 0QV2's revenue (7.5% per year) is forecast to grow faster than the UK market (3.3% per year).
Hoge groei-inkomsten: 0QV2's revenue (7.5% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: 0QV2 is forecast to be unprofitable in 3 years.